Want to join the conversation?
$ABT 2Q15 Call: Reported adjusted EPS of $0.52 was above guidance range and reflected another quarter of double-digit underlying growth. Sales increased double-digits operationally for the second consecutive quarter. Excluding the impact of 2014 acquisitions and ForEx, sales increased 6.5%, which reflects an acceleration of performance from 1Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?